Fadi Brimo
Impact in
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Renal cell carcinoma treatment 32
- Prostate Cancer Diagnosis and Treatment 30
- Prostate Cancer Treatment and Research 22
- Sarcoma Diagnosis and Treatment 9
- Surgery 71
- Bladder and Urothelial Cancer Treatments 59
- Urinary and Genital Oncology Studies 10
- Co-authors
- Wassim Kassouf (57 shared papers)Armen Garo Aprikian (52 shared papers)Jonathan I. Epstein (14 shared papers)Simon Tanguay (32 shared papers)Manon Auger (21 shared papers)Faysal A. Yafi (5 shared papers)Jordan R. Steinberg (3 shared papers)José João Mansure (18 shared papers)
- Journals
- Cell Reports (13 papers)Histopathology (13 papers)Human Pathology (12 papers)Cell (10 papers)The American Journal of Surgical Pathology (9 papers)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Fadi Brimo
204 papers receiving 31.5k citations
Fadi Brimo's Hit Papers
Peers
Comparison fields: 5 of 153
- Cancer Research 7.3k
- Oncology 7.5k
- Pulmonary and Respiratory Medicine 7k
- Molecular Biology 8k
- Genetics 956
Countries citing papers authored by Fadi Brimo
This map shows the geographic impact of Fadi Brimo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fadi Brimo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fadi Brimo more than expected).
Fields of papers citing papers by Fadi Brimo
This network shows the impact of papers produced by Fadi Brimo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fadi Brimo. The network helps show where Fadi Brimo may publish in the future.
Co-authors
The 25 scholars most cited alongside Fadi Brimo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 213 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Immune Landscape of Cancer Hit paper breakdown → | 2018 | 4385 |
| 2 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Hit paper breakdown → | 2018 | 2633 |
| 3 | The Molecular Taxonomy of Primary Prostate Cancer Hit paper breakdown → | 2015 | 2464 |
| 4 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Hit paper breakdown → | 2018 | 2371 |
| 5 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer Hit paper breakdown → | 2018 | 1758 |
| 6 | Comprehensive Characterization of Cancer Driver Genes and Mutations Hit paper breakdown → | 2018 | 1748 |
| 7 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation Hit paper breakdown → | 2018 | 1634 |
| 8 | Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas Hit paper breakdown → | 2018 | 824 |
| 9 | Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images Hit paper breakdown → | 2018 | 771 |
| 10 | Genomic and Functional Approaches to Understanding Cancer Aneuploidy Hit paper breakdown → | 2018 | 768 |
| 11 | Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients Hit paper breakdown → | 2018 | 696 |
| 12 | Pathogenic Germline Variants in 10,389 Adult Cancers Hit paper breakdown → | 2018 | 617 |
| 13 | Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Hit paper breakdown → | 2018 | 598 |
| 14 | The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma Hit paper breakdown → | 2018 | 580 |
| 15 | A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers Hit paper breakdown → | 2018 | 470 |
| 16 | Driver Fusions and Their Implications in the Development and Treatment of Human Cancers Hit paper breakdown → | 2018 | 457 |
| 17 | The Immune Landscape of Cancer Hit paper breakdown → | 2019 | 455 |
| 18 | Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas Hit paper breakdown → | 2018 | 431 |
| 19 | lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer Hit paper breakdown → | 2018 | 394 |
| 20 | Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer Hit paper breakdown → | 2018 | 384 |
About Fadi Brimo
Fadi Brimo is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Cancer Research, Oncology and Physiology, having authored 213 papers that have together received 31.9k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (59 papers), Renal cell carcinoma treatment (32 papers), Prostate Cancer Diagnosis and Treatment (30 papers), Prostate Cancer Treatment and Research (22 papers), Cancer Genomics and Diagnostics (20 papers), Urinary and Genital Oncology Studies (10 papers), Sarcoma Diagnosis and Treatment (9 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Cancer Research (7.3k citations), Oncology (7.5k citations), Pulmonary and Respiratory Medicine (7k citations), Molecular Biology (8k citations) and Genetics (956 citations). Fadi Brimo has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Wassim Kassouf, Armen Garo Aprikian, Jonathan I. Epstein, Simon Tanguay, Manon Auger, Faysal A. Yafi, Jordan R. Steinberg, José João Mansure, Charles Chuanhai Guo and Ming Zhou. Their work appears in journals such as Cell Reports, Histopathology, Human Pathology, Cell and The American Journal of Surgical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.